AACR 2026 现场信号· @ · X·· 2026-04-22评分60
正文 · 原文
At #AACR26, Henlius presented new data on HLX3902 (CD3×CD28×STEAP1 tri-specific #TCE), demonstrating best-in-class potential in prostate cancer. our in-house multispecific #TCE platform aims to overcome key barriers in #SolidTumor treatment.
Link: https://t.co/qWzWGA0nlQ https://t.co/UshEbd9Qma
热度 0 · 0 赞 · 0 回复 · 0 转发
来源:AACR 2026 现场信号 · x.com
